We are adding to our position in a sliding stock and reserve profits in a 2025 winner
We are doing a couple of trades on Monday when Wall Street Rallies to start the week.
investment strategy
We are lightening in a stock of rally that has become too big in our portfolio
The sale also occurs when our trusted impulse indicator moved more to the overcompra territory.
We are reducing our target price in Danaher as frustration is mounted after a messy quarter
Danaher's actions are under pressure on Wednesday, since the profit results of the fourth quarter of the Holding Club reached…
We are cutting a 2025 superior winner, obtaining profits in the movement of the market towards health actions
We are selling 75 shares of Ge Healthcare at approximately $ 90 each. After Monday's trade, Jim Cramer's charitable trust…
Our Five Best-Performing Stocks Since the December Monthly Meeting Are Tech-Free
It's been a topsy-turvy start to 2025 for the stock market. Since the Club's monthly meeting in December, Wall Street…
Strategas sees healthcare outperforming in 2025
The healthcare sector is poised to see a rebound and lead the market this year, according to analysts at Strategas,…
Stocks rise on cold inflation, hot bank profits and new rules on biotech exports to China
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
How much can you save if you don't drink for a month?
Ryanjlane | E+ | fake images The beginning of a new year is the most popular time to make a…
Eli Lilly's lead in the obesity race has increased. Its recent stock performance says otherwise.
Eli Lilly investors have received some very good news in recent months, with one notable exception regarding the stock's performance.…
Innovative biotech stocks have a good chance of breaking out in 2025
The trends may be turning in favor of biotech stocks in 2025 after several years of poor performance, but it…